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ABSTRACT 
 
Background: Guidelines are increasingly used to guide clinical practice, with the expectation 
that guidelines improve clinical outcomes and minimize health care expenditure. In recent 
years a number of guidelines for vaginal birth after cesarean section (VBAC) have been 
released or updated. The range of nationally produced guidelines for VBAC has created 
dilemmas for clinicians and consumers. The purpose of this study was to summarise the 
recommendations of existing guidelines and assess their quality using a standardized and 
validated instrument to determine which guidelines, if any, are best able to guide clinical 
practice. 
Methods: English language guidelines on VBAC were purposively selected from national 
and professional organisations in the UK, USA, Canada, New Zealand and Australia. The 
Appraisal of Guidelines for Research and Evaluation (AGREE) instrument was applied to 
each guideline. Each guideline was analyzed to determine the range and level of evidence on 
which it was based and the recommendations made.   
Results: Six guidelines published or updated between 2004 and 2007 were appraised. Only 
two of the six guidelines scored well overall using the AGREE instrument. There was 
heterogeneity in the evidence used. Most of the guidelines cited expert opinion and consensus 
as evidence for some recommendations. Reported success rates for VBAC ranged from 30-85 
percent; and reported rates of uterine rupture ranged from 0-2.8 percent. 
Conclusions: VBAC guidelines are characterized by quasi-experimental evidence and 
consensus based recommendations which lead to wide variability in recommendations and 
undermines their usefulness in clinical practice.  
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INTRODUCTION 
There is an increasing emphasis on developing guidelines for clinical practice to ensure the 
provision of high quality care, with a view to improving clinical outcomes and minimising 
health care expenditure (1). Effective guidelines should be based on high quality evidence, be 
clearly and practically written and accessible to health care providers and consumers. The 
impact of guidelines on practice is difficult to ascertain. According to the Institute of 
Medicine (2), “disproportionately more attention is paid to developing guidelines than to 
implementing or evaluating them”.  
 
In recent years, vaginal birth after cesarean section (VBAC) has received considerable 
attention from policy makers, clinicians and consumers. The safety and success of attempted 
VBAC has been debated in the literature, resulting in a wide variety of opinions and practices 
internationally. A number of countries have developed and implemented guidelines for 
VBAC but their impact on VBAC rates is unclear. A 1995 survey of American College of 
Physician Executives demonstrated an inconsistent implementation of national VBAC 
guidelines, with a reluctance to hold physicians accountable for VBAC rates (3).  
 
This study sought to critically appraise a sample of nationally produced guidelines regarding 
birth after cesarean section. We sought to determine the major recommendations in each 
guideline, the similarities and differences between the guidelines and the evidence on which 
each guideline was based. The null hypothesis was that there would be minimal differences in 
recommendations made by each guideline as the recommendations would be based on the 
highest quality evidence available, and this would be similar across guidelines, with 
allowances for the date of publication.  
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METHODS 
Guidelines regarding VBAC were purposively sought from the following organisations: 
Royal College of Obstetricians and Gynaecologists (RCOG) United Kingdom (UK), 
Women’s Hospitals Australasia (WHA), New Zealand Guidelines Group (NZGG), National 
Institute of Clinical Excellence (NICE) UK, the Society of Obstetricians and Gynaecologists 
of Canada (SOGC), Royal Australian and New Zealand College of Obstetricians and 
Gynaecologists (RANZCOG), American College of Obstetricians and Gynecologists 
(ACOG) and the Scottish Intercollegiate Guidelines Network (SIGN). This sample was 
selected as they represented the key national authorities in relation to obstetrics/maternity 
care in each of the six countries and are widely used to develop local clinical policies.  
 
The eight organizations were contacted regarding their VBAC guideline (Table 1). Six 
guidelines were obtained, either electronically or in hard copy. Two organizations, 
RANZCOG and SIGN, did not have published VBAC guidelines and were not included in 
the analysis.  
Insert Table 1 here 
 
Each guideline was analyzed using the Appraisal of Guidelines for Research and Evaluation 
(AGREE) instrument, which evaluates the validity of a guideline (4, 5) and is becoming the 
international gold standard for the evaluation and development of guidelines (6). The 
AGREE instrument is organised into six domains: Scope and purpose; Stakeholder 
involvement; Rigor of development; Clarity and presentation; Applicability; and Editorial 
independence. The instrument is endorsed by the World Health Organization (WHO) and has 
been used internationally for the development and quality of clinical practice guidelines (6, 
7). Two assessors independently analyzed each guideline using the AGREE instrument.  
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Each guideline was evaluated with respect to the recommendations concerning advice to 
women, clinicians and obstetric practices. Content analysis was undertaken on each guideline 
in relation to quotes from the respective guidelines.  
 
RESULTS 
The results are presented in four areas: (1) the results using the AGREE instrument; (2) 
success rates of VBAC; (3) rate of uterine rupture; and (4) recommendations for clinical 
practice.  
 
AGREE guideline analysis 
The appraisal of the guidelines based on the six domains of the AGREE instrument 
demonstrated a range of scores (Table 2). The NZGG and NICE guidelines scored highest on 
almost all domains especially Rigour of Development. This domain includes having a 
systematic approach to gathering the evidence; clear descriptions of the search methods and 
way of formulating recommendations; evidence of considering benefits and risks; 
demonstration of links between recommendations and the evidence; be externally reviewed 
by experts; and discuss updating procedures. 
 
Insert Table 2 here 
 
All guidelines received low scores for Applicability which includes the barriers and costs 
associated with implementation, monitoring and audit of outcomes. Only the NICE 
guidelines scored highly for Editorial Independence which includes conflicts of interest and 
independence. A low score was also given if the guideline did not address the criteria. 
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Vaginal birth after cesarean section success and uterine rupture rates 
The reported VBAC success and uterine rupture rates vary markedly between guidelines 
(Table 3) as does the evidence on which the reported rates were based. The lowest rate for 
VBAC success is reported by NICE (30 – 51 percent success rate) and is based solely on a 
UK national cesarean section audit (8). The WHA guideline does not provide explicit in-text 
referencing. In the four remaining guidelines, there were only three references that were 
common to more than one guideline (9-11) and none was cited in more than two guidelines. 
Despite being published in 2005, the SOGC guideline references tended to be older, with all 
but two of the nine references published before 1999. In contrast, the RCOG guideline 
references six papers, all published between 2000 and 2004. The published range for VBAC 
success is narrowest in the RCOG guidelines and widest in the SOGC guidelines.  
 
Insert Table 3 here 
 
Uterine rupture rates 
Uterine rupture is a significant complication of VBAC. Quoted rates of uterine rupture vary 
between guidelines but are all less than 3 percent and most are less than 1.5 percent (Table 3). 
The highest rate comes from NICE. This guideline states that the range of 0-2.8 percent is 
derived from a review of 39 quasi-experimental studies quoting rupture rates, however only 
six studies are directly cited. In two other places in the guideline, rates of 0.35 percent (p.15) 
and 0.5 percent (p.18) are also reported as overall rates of uterine rupture, without 
explanation as to the source of these rates. The guideline states that the larger and better 
conducted studies report lower rates of uterine rupture with VBAC. The International 
Classification of Diseases, ninth revision – clinical modification (ICD-9-CM –now ICD-10-
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CM) codes used in hospital discharge data to identify uterine rupture have been notably 
inaccurate (12) and may have contributed to the wide ranges in these guidelines.  
 
The NZGG report a range of 0.2 - 1.5 percent for uterine rupture, which is taken from a 
literature review of VBAC (12) but elsewhere in the guideline quotes the rate of 0.52 percent 
for women attempting VBAC who labor spontaneously (13). The SOGC guideline quotes the 
same rates as NZGG but only two references are common to both guidelines. The references 
cited in the SOGC guideline are not common to the review by Scott (13) on which the overall 
NZGG rate of 0.2-1.5 percent is largely based. Across all guidelines, there are 22 individual 
references for uterine rupture. Five references are cited in two guidelines (9, 11, 15-17) and 
two references are cited in three guidelines (10, 18). Although this shows greater similarity 
than the evidence cited regarding VBAC success 15 of the references across the guidelines 
only appear in one guideline. Overall the highest rates for uterine rupture quoted in each 
guideline ranged from 0.3 percent (WHA) to 2.8 percent (NICE).  
Figure 1 provides the upper and lower range of VBAC success and the highest rate of uterine 
rupture across the six guidelines and reveals the ‘outlier’ position assumed by the NICE 
guideline on both rates. 
 
Insert Figure 1 here 
 
Recommendations for clinical practice 
The guidelines provide a range of recommendations in relation to clinical practice (Table 4).  
Insert Table 4 here 
Only two guidelines recommend that women ‘should be offered’ a planned VBAC or trial of 
labor (NZGG, SOCG). The remaining four guidelines use language that is more ambiguous 
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ranging from ‘should be provided with information’ (WHA) to ‘ultimate decision should be 
between the woman and her physician’ (ACOG). 
 
Continuous electronic fetal monitoring in women having a VBAC is ‘recommended’ in two 
guidelines (SOCG, WHA); ‘advised’ in one (RCOG) and ‘should be offered’ in another 
(NICE). The NICE guideline also recommends fetal blood sampling if fetal acidosis is 
suspected. The ACOG guideline states that ‘most authorities recommend continuous 
electronic fetal monitoring’. The NZGG states that there is no evidence to support or refute 
the use of continuous electronic fetal monitoring in women having a VBAC, although fetal 
heart rate abnormalities are the most common indicator of uterine rupture.  
 
Four guidelines base their claims of recommending continuous electronic fetal monitoring in 
labor on it being a ‘good practice point’ (that is, Level C evidence - a consensus opinion). 
The SOGC guideline states that the recommendation is based on Level II-2A evidence 
(evidence obtained from at least one well-designed controlled study without randomisation). 
However, the evidence cited in support of this statement does not relate to Level II evidence: 
one reference is to the 1999 version of the ACOG VBAC guidelines, one is a literature 
review of VBAC in which the author states “I prefer to use continuous electronic monitoring 
for all these patients” (13) and the final reference is for a (now superseded) SOGC guideline 
for fetal surveillance in labor in which VBAC is not specifically covered (19). None of these 
publications provide high quality evidence regarding the use of continuous electronic fetal 
monitoring for women having a VBAC.  
 
Epidural anaesthesia is addressed in four of the guidelines, but two (NICE, SOCG) make no 
comment at all. Two that make comment on epidural anaesthesia (RCOG, ACOG) state that 
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epidural anaesthesia is ‘not contraindicated’ and the others state that it ‘may be used as 
indicated’ (WHA) and ‘may be offered’ (NZGG).  
 
Each of the guidelines is supportive of induction of labor with a range of qualifying 
recommendations regarding the methods of inducing labor. Three specifically recommend 
against the use of prostaglandins for cervical ripening/induction of labor (WHA, SOCG, 
ACOG). The NZGG guideline distinguishes between PGE1 and PGE2 stating that “there is 
no evidence to suggest that induction of labor with [synthetic] oxytocin or PGE2 has 
significantly higher rates of uterine rupture compared to spontaneous labor” (page 44).  
 
Augmentation of labor is also supported with statements such as ‘not contraindicated’ 
(RCOG, WHA); ‘can be offered’ (NICE) and ‘careful use of syntocinon [synthetic oxytocin] 
may be considered’ (NZGG). One guideline fails to mention augmentation at all (SOCG) and 
the ACOG mentions augmentation by stating ‘spontaneous labor is more likely to result in 
successful VBAC than induction of labor or augmentation’.  
 
DISCUSSION 
This paper has highlighted significant differences between six national guidelines concerning 
VBAC published between 2004 and 2007. The diversity of quality and the range of reported 
success rates, risks of uterine rupture, use of continuous electronic fetal monitoring and 
induction of labor are the main differences across the guidelines. We recognise that VBAC is 
a challenging area of practice as the clinical issues for each woman vary. For example, the 
situation of a woman who had not had a prior vaginal birth who is 41.5 weeks gestation with 
an unripe cervix facing induction is significantly different in terms of VBAC success and 
uterine rupture risk than a woman with a prior successful VBAC in spontaneous labour. The 
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variation in outcomes makes guideline development difficult as a ‘one size fits all’ approach 
will not always work. Nonetheless, many institutions and clinicians use the guidelines to 
dictate policy and practice for all women and the clinical nuances that guide decision making 
are lost.  
 
Guideline development is also hampered by timing. New evidence invariably emerges soon 
after a guideline is published and may put the guideline at odds with the most recent evidence 
and clinical practice, adding to the inconsistencies. Since three of the guidelines were 
produced, a large prospective multicenter observational study of over 33 000 women with 
prior cesarean delivery undergoing trial of labor and elective repeat operation has been 
published (20). This landmark study demonstrated that a trial of labor was associated with a 
greater perinatal risk than is elective repeated cesarean delivery without labor, although 
absolute risks were low. Symptomatic uterine rupture occurred in 124 women who underwent 
a trial of labor (0.7 percent). None of the guidelines reviewed has been updated to include this 
important study. 
 
The AGREE instrument  
The AGREE analysis demonstrated considerable limitations in all six guidelines. Only two 
guidelines (NICE, NZGG), scored high in the majority of domains. The AGREE instrument 
does not distinguish guidelines in relation to accuracy of interpretation of evidence. AGREE 
is a generic tool used to assess bias regarding the rigor of guideline development and 
methodology. It is not designed to assess the clinical content of a guideline nor does it assess 
the quality of the evidence on which recommendations are based (5). Vlayen et al. (21), in an 
assessment of 24 clinical practice guideline appraisal tools (including AGREE), concluded 
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that the examination of evidence within a guideline should be incorporated into appraisal 
tools and this was lacking in all the appraisal tools evaluated.  
 
Our study further highlights limitations in the AGREE instrument. Although the NICE 
guideline scored highest using AGREE, analysis of the evidence on which some of the 
recommendations are based caused some concern. VBAC success rates reported in the NICE 
guideline were based solely on a national audit of cesarean section conducted in the UK. 
Better quality evidence, such as rates reported in large cohort studies, would be more 
appropriate and likely provide a more accurate estimate of VBAC success. There appears to 
be no assessment of trial quality within the guideline when reporting on uterine rupture 
despite inclusion of trials of lower quality which can greatly exaggerate an effect (22). Other 
studies have also found a lack of validity of evidence when using the AGREE tool (23, 24). 
 
Differences across guidelines 
The guidelines reviewed are characterised by quasi-experimental evidence which leads to 
wide variability in recommendations and undermines their usefulness in clinical practice. 
Despite the guidelines being developed in similar time frames (2004-2007) the evidence 
selected for inclusion differs widely. For example, of the 22 individual publications cited 
across the six guidelines regarding VBAC success rates, only three are cited in two 
guidelines. Although there was a higher degree of agreement for uterine rupture rate 
references, a large proportion (15/22) of the references cited did not appear in more than one 
guideline. This questions the search strategies of the guideline developers given the similarity 
in scope and purpose. 
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The range of reported uterine rupture rates in the guidelines poses a challenging issue for 
clinicians and consumers alike. NZGG report a range of 0.2 - 1.5 percent for uterine rupture, 
which is taken from a literature review of VBAC (13) but elsewhere quotes the rate of 0.52 
percent for women attempting VBAC who labor spontaneously (14). This discrepancy 
suggests the guideline authors believe that the original range of 0.2-1.5 percent includes 
women who undergo induction of labor. If so, this is particularly misleading given that 
induction, particularly with the use of prostaglandins, had been shown to increase the risk of 
uterine rupture (17). Comparisons of uterine rupture rates are compounded with limitations in 
coding and verification of uterine rupture. In addition, prospective population-based studies 
may yield different results than retrospective audits that depend on accurately coded data. 
The wide variability in quoted rates challenges clinicians when counselling women as to the 
most appropriate mode of birth. It also creates confusion and uncertainty for pregnant 
women.  
 
The variation in clinical practice recommendations in relation to mode of birth, continuous 
electronic fetal monitoring, epidural anaesthesia, induction and augmentation of labor also 
creates dilemmas for clinicians and consumers. Many of these recommendations are based on 
consensus decision-making rather than research evidence. Although a consensus opinion of 
experts may be appropriate where evidence is lacking, it is important that guidelines are 
transparent in their methodology and clearly outline areas where there is insufficient evidence 
and expert opinion has been used. Many of the recommendations within the VBAC 
guidelines are written with a degree of certainty which, given the lack of evidence, is 
incongruous.  
 
The influence of guidelines in clinical practice 
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There are few studies that assess the impact of national VBAC guidelines on local practice 
(25, 26). In the 1980s and 1990s, ACOG took a very pro-VBAC stance as a strategy to reduce 
the rising cesarean section rate. In 1999, however, ACOG revised the guideline to take a 
more conservative approach involving close monitoring in labor and offering VBAC only 
where there is a “physician immediately available to provide emergency care” (27). This 
recommendation was based on Level C evidence (a consensus opinion of experts) that VBAC 
may be associated with increased neonatal mortality (25). Despite the lack of high quality 
evidence on which the changes were based, the effect on services providing VBAC was very 
significant. Roberts et al. (25) reported that over 30 percent of services that were previously 
offering VBAC no longer continued do so after the change in guidelines. Smaller and more 
isolated hospitals were more likely to discontinue offering VBAC. Of those that continued to 
offer VBAC, the majority (68 percent) changed their policies in line with the provision of 
onsite surgical and anesthetic staff. Similarly, in California, attempted VBAC fell from 24 
percent to 13.5 percent following the new guidelines (26). 
 
The outcomes of these studies highlight the influence that national bodies such as ACOG can 
have on clinical practice. Given that the changes to the ACOG guidelines were not based on 
high quality evidence, but on a consensus of expert opinion, and many organisations choose 
not to include all ACOG’s recommendations (28), the impact on the practice of VBAC across 
the US is concerning.  
 
Our study is limited in a number of ways. The selection of guidelines was purposive in that it 
chose guidelines that are widely used, and referred to, and have a high profile in the clinical 
arena. There are many other guidelines from professional associations and hospitals, health 
services or health departments. It was outside the scope and purpose of this study to appraise 
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all of these. In addition, it is highly likely that these less prominent guidelines would have 
drawn heavily on the ones that were selected. The study was a document analysis of the 
guidelines. Discussion with the guideline developers and/or the issuing authority did not 
occur. In addition, only two reviewers undertook the AGREE analysis.  
 
CONCLUSION 
This review of a number of high profile guidelines for the care of women who have had a 
previous cesarean section demonstrated wide variation in terms of rigor and applicability of 
the guideline itself. The majority of the guidelines scored poorly using the AGREE 
instrument. The AGREE instrument is significantly limited as a means to assess the quality of 
guidelines as it does not assess the accuracy of the evidence reported. It is only a means to 
assess the process of development.  
 
There were also a number of differences in relation to internal consistency with respect to the 
main rates quoted – rate of successful VBAC and rate of uterine rupture. The variations 
between, and the lack of appreciation of the limitations or imprecision within, the guidelines 
create difficulties for clinicians and consumers. None of these guidelines has been recently 
reviewed or updated despite the availability of new, high quality evidence that may alter 
many guideline recommendations (20). This needs to be undertaken. 
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Table 1: VBAC guidelines analyzed, their source and year of most recent update 
Guideline Publisher Origin Source Last update 
Royal College of Obstetricians 
and Gynaecologists (RCOG) 
United Kingdom Website (30) 2007 
Royal Australian and New 
Zealand College of Obstetricians 
and Gynaecologists (RANZCOG) 
Australia and New 
Zealand 
No guideline 
available 
NA 
Women’s Hospital Australasia 
(WHA) 
 Website (31) 2005 
Scottish Intercollegiate 
Guidelines Networks (SIGN) 
Scotland No guideline NA 
National Institute of Clinical 
Excellence (NICE) 
United Kingdom VBAC is part of a 
larger guideline for 
Cesarean Section (32) 
2004 
New Zealand Guidelines Group 
(NZGG) 
New Zealand Website (33) 2004 
Society of Obstetricians and 
Gynecologists of Canada (SOGC) 
Canada Journal (34) 2005 
American College of 
Obstetricians and Gynecologists 
(ACOG) 
United States of 
America 
Received hard copy 
version from ACOG 
(35)  
2004 
 
21 
 
 
Table 2: AGREE analysis of the 6 national VBAC guidelines. 
 Domain 1: 
Scope and 
purpose  
% 
Domain 2: 
Stakeholder 
involvement 
% 
Domain 3: 
Rigour of 
development 
% 
Domain 4: 
Clarity and 
presentation 
% 
Domain 5: 
Applicability 
 
% 
Domain 6: 
Editorial 
independence 
% 
Recommend for 
use in practice* 
 
RCOG 89 50 55 67 33 0 No 
WHA 50 0 0 58 6 0 No 
SOGC 100 50 33 75 17 0 No 
NZGG 100 71 81 100 33 42 Yes 
NICE 100 75 86 100 0 100 Yes 
ACOG 100 21 50 58 11 0 No 
*Would you recommend these guidelines for use in practice? 
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Table 3: VBAC success and uterine rupture rates reported in the six VBAC guidelines  
 
Guideline  
Publisher 
Success Rate 
 (%) 
Uterine rupture rate Uterine rupture rate as a percentage range 
RCOG 72 – 76 Eight rates quoted ranging from 
22/10,000 to 74/10,000 
0.2– 0.7% 
WHA 70 – 80 One rate quoted: 30/10,000 0.3% 
NZGG 60 – 80 Two rates/ranges quoted: 0.2-1.5% 
and 5.2/1000 
0.2–1.5% 
NICE 30 – 51 Three rates/ranges quoted: 0 – 
28/1000,  35/10,000 and 50/10,000 
0.0–2.8% 
SOGC 50 – 85 One range quoted: 0.2-1.5% 0.2–1.5% 
ACOG 60 – 80 One rate quoted: <1% <1% 
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Table 4. Summary of the main practice points as described in each guideline.  
 RCOG WHA NZGG NICE SOGC ACOG 
Choice of 
mode of birth 
Should be able to 
discuss the 
option of 
planned VBAC 
Women who want 
a vaginal birth 
should be 
supported with 
information’ to aid 
their choice 
Should be offered a 
planned VBAC 
Women who want a 
vaginal birth ‘should be 
supported with 
information’ to aid their 
choice 
‘Should be 
offered’ a Trial 
of labor 
Ultimate decision 
should be between 
the woman and her 
physician 
Electronic fetal 
monitoring 
during labor 
Should be 
advised to have  
 
Should  be 
recommended  
Possible risks and 
benefits should be 
discussed – no 
evidence that EFM 
improves 
outcomes’ 
Should be offered  Recommended  Most authorities 
recommend 
continuous EFM 
 
Epidural 
anaesthesia 
during labor 
Not 
contraindicated 
May be used as 
indicated 
May be offered Not examined Not examined Not 
contraindicated 
Induction of 
labor 
Discuss risk if 
induction of 
labor required 
 
PGs should not be 
used 
IOL may be offered  
Not PGE1, PGE2 
appears OK 
 
Can be offered Not 
contraindicated 
if oxytocin used, 
PGs should not 
be used 
Use of PGs should 
be discouraged 
Augmentation 
of labor 
Not 
contraindicated 
Not contraindicated Careful use of 
syntocinon may be 
considered 
Can be offered Not mentioned Spontaneous labor 
more likely to 
result in VBAC 
than IOL or 
augmentation 
Key: IOL = Induction of labor; EFM = electronic fetal monitoring; PG = prostaglandin 
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Figure 1: Upper and lower range of VBAC success reported in 6 guidelines together with variations in reported uterine rupture 
rates. The highest reported value of uterine rupture in each guideline is presented. 
 
 
 
